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INTRODUCTION
MANDATORY TESTING OF PREGNANT
WOMEN AND NEWBORNS: HIV, DRUG USE,
AND WELFARE POLICY
Elizabeth B. Cooper*
The issues presented by the Symposium's second panel are
among the most difficult facing ethicists, policy-makers, health-
care providers and healthcare consumers. In the historical context
of HIV testing, individual autonomy and consent have been highly
respected values. Many states, including New York,' have codified
a thoughtful counseling and consent process in their public health
statutes.2 Recent developments in medical treatment and preven-
tion, however, have caused some attitudes toward HIV counseling
and testing to shift.
The pressure to change these procedures is felt most significantly
in the realm of HIV testing of pregnant women and newborns. As
our panelists' contributions represent, there is a diverse set of ap-
proaches to this subject matter. Some believe strongly that man-
dated testing is the most effective way to ensure that a newborn
receives HIV-related health care. Others counter that, especially
for people living in poverty, the lack of meaningful access to care
and services, and the risk of HIV-related discrimination, are too
great to permit mandated testing.
Thus far, mandated testing largely has been rejected by state and
administrative bodies. However, effective February 1, 1997, New
York State was the first to order that every newborn in the state
will be mandatorily tested for HIV-antibodies.3 The results of the
test will be disclosed to the delivering woman, her physician, and
her child's physician. The test will reveal whether the child's
mother is HIV-infected. If she is, it also will reveal that the child
has an eight to twenty-five percent chance of being infected.
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1. N.Y. PuB. HEALTH LAW § 2781 (McKinney 1993 & Supp. 1997-98).
2. See, e.g., FLA. STAT. ANN. § 384.31 (West 1993 & Supp. 1998); N.J. STAT. ANN.
§ 26:5C-16 (West 1996); TEX. HEALTH & SAFETY CODE ANN. § 81.090 (West 1992 &
Supp. 1998).
3. NEW YORK COMP. CODES R. & REGS. tit. 10, § 69 (1997).
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Is this good public health practice? Some assert that the contro-
versy surrounding mandated testing, is, at its heart, an issue of ma-
ternal privacy versus child health rights, and the latter must prevail.
They argue that only by knowing that a newborn is HIV-infected
will the child be able to get necessary care and services. Others
reject that paradigm, asserting that it is a false construct. Rather,
they argue that the best way to ensure necessary health care for the
child-and the mother-is to work with the mother, providing her
with counseling and the option to test. They contend that working
with the mother through counseling is the best way to ensure that
both mother and child get necessary care and services.
Analogous structures of analysis frequently appear when consid-
ering the increasingly intermingled questions of drug toxicology
testing of newborns and the impact of "welfare reform" on the
lives of those subject to these policy debates. This discussion, in
particular, occurs within an encroaching aura of criminalization of
public healthcare policy concerning women and their children.
The following collection of essays provides a concise and in-
sightful treatment of the bioethical, legal, and public health con-
flicts present in the difficult terrain our panelists were asked to
address. The richness of our panelists' diverse backgrounds is well-
reflected in their contributions. They grapple head-on with the
place of race, class, and gender in the evolution of public health
policies affecting the lives of women and their children. Just as im-
portant, they address the inherent stretches that traditional princi-
ples of law and ethics must make to accommodate technologies
and medical realities unimaginable just fifteen years ago. I hope
you will find them as enriching as I have found them to be.
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